MHA is committed to working with member hospitals, the Governor’s administration, the legislature, other providers, and most importantly, patients, to curb the current opioid crisis in Massachusetts. Below please find a series of guidelines developed by MHA to assist hospitals in creating programs for Medication for Addiction within the Emergency Department, Opioid Management within a Hospital Setting, Emergency Department Opioid Management, and for Preventing Opioid Misuse in Hospitals.
Additional resources below include: websites to identify substance use disorder treatment providers and locations, training to allow practitioners to prescribe buprenorphine, and websites with information from experts in substance use disorder treatment.
Guidelines for Medication for Addiction Treatment for Opioid Use Disorder within the Emergency Department
MHA, in collaboration with the Massachusetts College of Emergency Physicians and with practitioners from member hospitals, including specialists in emergency medicine, addiction medicine, behavioral health, and nursing, developed these guidelines to assist hospitals in developing Medication for Addiction Treatment (MAT) programs in emergency departments or satellite emergency facilities.
These guidelines focus primarily on buprenorphine, which has the most well-developed evidence base for feasibility and efficacy in the emergency department setting. The information includes:
- Clinical and operational recommendations;
- Prescribing guidelines, including information for practitioners on how to obtain an X waiver to prescribe buprenorphine;
- Information on the laws and regulations in place to allow hospitals to discharge patients with a take-home kit of buprenorphine;
- Template/customizable patient fact sheets; and
- A provider directed Q & A.
The guidelines are available here: Guidelines for Medication for Addiction Treatment for Opioid Use Disorder within the Emergency Department
Customizable versions of the two patient fact sheets are available here:
Guidelines for Opioid Management within a Hospital Setting
The MHA Substance Use Disorder Prevention and Treatment Task Force (SUDPTTF) approved and issued a second set of guidelines outlining several provider and operational recommendations related to prescribing opioid and/or opiate medications within a hospital setting, including hospital owned/affiliated clinics or physician practices. The goal is to develop a general standard for limiting the use of or finding alternatives to prescription opioids. We encourage all hospitals to adopt the recommendations. The guidance includes the following materials:
- Guidelines for Opioid Management by Clinicians and Staff within a Hospital Setting
- Suggested Opioid Prescribing Guidelines Flowchart, - Provides a quick, visually graphic picture of the prescribing process for physicians and providers who prescribe opioids as outlined in detail within the guidelines.
- Physician/Prescriber Reminders When Prescribing Opioids, - Jointly issued by MHA and Massachusetts Medical Society, - Provides a quick checklist of reminders for physicians and prescribers to reference when issuing opioid medication.
- Pain Stewardship Program – Jointly released by Beth Israel Deaconess Hospital- Plymouth and Mallinckrodt Pharmaceuticals, provides acute pain management resources and tools to help institutions educate patients and provide improved assessments and non-opiate treatments options for acute pain.
- Provider Core Competencies, - Jointly issued by MHA, MMS, COBTH, and DPH – Hospitals with a residency and/or fellowship program are requested to include these core competencies as part of their trainings to ensure that all future providers are aware of and meeting expected prescribing standards for opioids.
- Naloxone Standing Order Best Practices,- A summary of the state - recommended steps that facilities should follow if they choose to adopt a standing order within their internal pharmacies.
- Template Patient Fact Sheet, - Jointly issued by MHA and Massachusetts Medical Society, - It is recommended that patients are provided this form when a prescription opioid is issued (or a provider may use some or all of this language in your existing fact sheets provided to patients)
- Folha de informações ao paciente (Portuguese patient fact sheet)
- Hoja informativa para el paciente ((Spanish patient fact sheet)
- Template Medication Storage Fact Sheet, - Proposed recommendations for safe and appropriate storage of opioid medications within a patient’s residence that may also be provided to patients when a prescription is issued.
- Available Drug Disposal Options, - Provides an overview of local and statewide appropriate and safe disposal options for opioids. Also provides space for a hospital to include information on disposal options within each facility, if available.
- Hospital Commitment Letter, - Asking all hospitals to complete to demonstrate their commitment to each of the six provider and eight operational recommendations.
Guidelines for Emergency Department Opioid Management
These guidelines establish a baseline emergency department (ED) operational practice that will: standardize opioid prescribing practices, provide guidance on screening patients seeking opioid prescriptions, offer information on appropriate pain management and treatment, and help identify resources for patients needing substance use treatment. The overall goal is to better enable ED providers to take an active role in limiting inappropriate access to opioid pain medications. The materials include the following:
- MHA Guidelines for Emergency Department Opioid Management
- Emergency Department Opioid Management Patient Information Sheet
Guidelines for Preventing Opioid Misuse in Hospitals
The Massachusetts Health & Hospital Association (MHA) and Tufts Medical Center, working with hospital clinicians and operational staff in Massachusetts and other states developed the following two documents that outline a patient centered approach to for the prevention of opioid misuse by patients admitted for care and treatment in a hospital inpatient setting:
The Inpatient Opioid Misuse Prevention Guidelines identify best practices (clinical practices and operational policies) to optimize patient care through standardizing
- Screening for opioid use disorder among patients admitted for inpatient level care;
- Prevention of inpatient acute opioid withdrawal through opioid agonist treatment (OAT);
- Working with patients and visitors to identify and prevent non-prescribed opioids from being brought into a hospital setting.
The Patient and Family Agreement on Opioids was written specifically for patients, families, and visitors. Among the goals of developing a patient centric model of care, the document outlines the roles and responsibilities of the patient and families/visitors to work with hospitals to reduce the presence of non-prescribed opioids within a hospital setting that may adversely impact a patient’s care and treatment.
- The President's Commission on Combating Drug Addiction and the Opioid Crisis
- AHA's Stem the Tide: Addressing the Opioid Epidemic
- Screening Tools Resource Packet
- MHA Annual Emergency Medicine Conference 2015 Slide Deck – All Presentations
- CDC AHA Prescription Opioids, What you need to know, June 2016
- Ongoing Hepatitis A Outbreak among Persons Experiencing Homelessness & Substance Use Disorder - DPH Aug 22, 2018 Advisory
- Find physicians authorized to treat opioid dependency with buprenorphine by state. Read more......» Full ArticleSearch for treatment by service, town and search programs by gender, age health insurance or without health insurance. Read more......» Full ArticleBoth National & Local Resources Available For nearly 25 years, BMC has been caring for patients with addiction, and recognizing that one size doesn’t fit all when it comes to treatment. A national model for care, BMC has developed tailored treatment programs that meet patients where they are, be it primary care, prenatal care, psychiatry, adolescents, the Emergency Department, or as an in...» Full ArticleThe most recent opioid law, Chapter 208 of the Acts of 2018, requires acute care hospital emergency departments to have the capacity to initiate opioid agonist treatment, including buprenorphine. To aid hospitals in implementing this policy, Boston Medical Center Grayken Center for Addiction and DPH’s Bureau of Substance Addiction Services are sponsoring four free buprenorphine “x-waiver”...» Full ArticleOn Wednesday, October 10th -- 12:00 - 1:00pm The Joint Commission will host a complimentary webinar that will feature speakers Dr. Jeanmarie Perrone, of the University of Pennsylvania Medical Center, and Dr. Scott Weiner, of Brigham and Women's Hospital. They will share their experiences with setting up programs to encourage safe prescribing of opioids and reducing opioid-related deaths. Rea...» Full Article